BeyondSpring Inc. — Investor Relations & Filings
Filings indexed
233
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
BYSI
BeyondSpring Inc. is a clinical-stage biopharmaceutical company that develops innovative immuno-oncology cancer therapies. The company's primary focus is on addressing unmet medical needs and improving clinical outcomes for cancer patients. Its pipeline includes a lead asset, Plinabulin, which is a first-in-class small molecule agent. Additionally, the company operates a Targeted Protein Degradation (TPD) platform to advance other potential treatments. BeyondSpring is committed to developing novel cancer therapies to enhance the standard of care in oncology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-05-13 | English | |
| 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-03-25 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| FORM 8-K | 2025-12-15 | English | |
| FORM 8-K | 2025-11-21 | English | |
| 424B5 | 2025-11-17 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 45554257 | 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-05-13 | English | ||
| 33040006 | 8-K - BeyondSpring Inc. (0001677940) (Filer) | 2026-03-25 | English | ||
| 31261765 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
12 filings
| |||||
| 12967326 | FORM 8-K | 2025-12-15 | English | ||
| 12967325 | FORM 8-K | 2025-11-21 | English | ||
| 12967327 | 424B5 | 2025-11-17 | English | ||
| 12967328 | FORM 10-Q | 2025-11-12 | English | ||
| 12967329 | FORM 8-K | 2025-11-12 | English | ||
| 12967330 | Director's Dealing 2025 | 2025-10-20 | English | ||
| 12967331 | Director's Dealing 2025 | 2025-10-15 | English | ||
| 12967333 | Director's Dealing 2025 | 2025-10-10 | English | ||
| 12967332 | Director's Dealing 2025 | 2025-10-07 | English | ||
| 12967334 | Director's Dealing 2025 | 2025-10-02 | English | ||
| 12967335 | Director's Dealing 2025 | 2025-09-29 | English | ||
| 12967336 | Director's Dealing 2025 | 2025-09-24 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
BeyondSpring Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34404/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34404 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34404 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34404 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34404}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BeyondSpring Inc. (id: 34404)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.